Skip to main content
Sedana Medical logo

Sedana Medical — Investor Relations & Filings

Ticker · SEDANA ISIN · SE0015988373 LEI · 549300FQ3NJRI56LCX32 ST Manufacturing
Open in API
Filings indexed 83 across all filing types
Latest filing 2026-04-24 Proxy Solicitation & In…
Country SE Sweden
Listing ST SEDANA

About Sedana Medical

https://sedanamedical.com/

Sedana Medical is a medical technology and pharmaceutical company specializing in inhaled sedation for mechanically ventilated patients in intensive care. The company develops, manufactures, and markets medical devices and pharmaceuticals, including its primary product, the AnaConDa (Anaesthetic Conserving Device). This system is designed for the administration of volatile anesthetics in intensive care units. The company's mission is to establish inhaled sedation as a standard therapy, aiming to improve patient outcomes and quality of life during and after the sedation period.

Recent filings

Filing Released Lang Actions
Sedana Medical kallar till årsstämma
Proxy Solicitation & Information Statement Classification · 89% confidence The document is a press release (“PRESSMEDDELANDE”) entitled “Sedana Medical kallar till årsstämma” which provides the formal notice to shareholders of the Annual General Meeting, including registration instructions, agenda items, and board and nomination committee proposals. This is a solicitation of proxies and information sent to shareholders in advance of a shareholder meeting, rather than the actual meeting materials or voting results. Therefore the correct filing category is a Proxy Solicitation & Information Statement (PSI).
2026-04-24 Swedish
Notice of Annual General Meeting in Sedana Medical
Proxy Solicitation & Information Statement Classification · 90% confidence The document is clearly a notice convening the company’s Annual General Meeting, including the meeting date, agenda items, details on proxy voting, nomination committee proposals, and explanatory information on resolutions. This is not simply an announcement of report publication but the full informational materials sent to shareholders to solicit votes for the AGM. Under our taxonomy, this corresponds to a Proxy Solicitation & Information Statement (PSI).
2026-04-24 English
Interim / Quarterly Report 2026
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for Sedana Medical AB for the period January-March 2026 (Q1). It contains detailed financial statements, including income statements, cash flow analysis, and management commentary on business performance, market potential, and strategic priorities. It is a comprehensive quarterly report, not an announcement or a summary, and therefore fits the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-04-23 Swedish
Interim / Quarterly Report 2026
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report' for the period 'January-March 2026'. It contains detailed financial summaries, including net sales, gross profit, EBITDA, operating income, and cash flow statements, as well as management commentary on business performance. It is a comprehensive quarterly financial report, not an announcement or a summary, and therefore fits the definition of an Interim/Quarterly Report. Q1 2026
2026-04-23 English
Earnings Release 2025
Earnings Release Classification · 95% confidence The document is a 'Bokslutskommuniké' (Year-end report) for Sedana Medical AB for the period January-December 2025. It contains detailed financial summaries, a CEO statement, significant events, and market potential analysis. While it covers the full year, in Swedish financial reporting, a 'Bokslutskommuniké' is the standard format for the preliminary annual financial results before the formal audited Annual Report (10-K equivalent) is published. Given the structure and content, it functions as an Earnings Release/Interim Report hybrid, but fits best under the 'Interim / Quarterly Report' category as it provides comprehensive financial performance for the period. FY 2025
2026-02-12 Swedish
Annual Report 2025
Annual Report Classification · 100% confidence The document is a 'Year-end report' for Sedana Medical AB covering the period January-December 2025. It contains detailed financial summaries, including income statements, cash flow data, and management commentary (CEO comments) on performance and strategic priorities. As it covers a full fiscal year and provides comprehensive financial results, it is classified as an Annual Report (10-K equivalent for non-US entities). FY 2025
2026-02-12 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.